Coumarins and betulinic acid analogues from Mammea americana and their inhibitory activities on oncogenic MAPK/ERK and PI3K/AKT pathways in human melanoma cells
Phytochemistry · 2025
DOI: 10.1016/j.phytochem.2025.114580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2025. Verfasst von Ruzhe Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Basel, Basel, 4056, Switzerland. Hauptthemen laut MEDLINE: Coumarins, Proto-Oncogene Proteins c-akt, Melanoma, Triterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Universitätsspital Zürich, Université de Genève.
Abstract (Originalsprache)
Melanoma, a highly aggressive form of skin cancer, is primarily driven by two key oncogenic signaling pathways: MAPK/ERK and PI3K/AKT. In a discovery program aiming to identify natural products that inhibit one or both pathways, an in-house library of 2'576 plant extracts was screened using a high-content screening assay with melanoma cells expressing ERK/AKT activity biosensors to quantify inhibition at the single-cell level. The ethyl acetate extract from the leaves of Mammea americana was found to inhibit both pathways in the patient-derived cell line MM121224 and was selected for HPLC-based activity profiling. Scale-up isolation of the compounds eluting in the active window of the chromatogram afforded ten previously undescribed betulinic acid analogues (1-10), along with nine known coumarins (11-19). The isolated compounds were individually evaluated for their inhibitory activity on ERK and AKT in MM121224 cells. Interestingly, none of the betulinic acid derivatives 1-10 showed activity in the assay. In contrast, the isolated coumarins were shown to inhibit both pathways, with the most potent theraphin B (11) exhibiting an IC50 value of 37.0 ± 0.4 μM against the AKT pathway, while also demonstrating weaker activity against the ERK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Basel, Basel, 4056, Switzerland.
- Institute of Cell Biology, University of Bern, Bern, 3012, Switzerland.
- Centro de Investigaciones Farmacognosticas de la Flora Panameña - Dr. Mahabir P. Gupta, Faculty of Pharmacy, University of Panama, Panama City, 3366-4, Republic of Panama.
- Department of Pharmaceutical Sciences, University of Basel, Basel, 4056, Switzerland. Electronic address: eliane.garo@unibas.ch.
Förderung
- China Scholarship Council
- Universitätsspital Zürich
- Université de Genève
- University of Bern
- Universität Basel
Zitieren
APA
Han, R., Balsiger, T., Dobrzyński, M., Dürr, L., Hell, T., Smieško, M., Solis, P. N., Hamburger, M., Pertz, O., Teufel, R., & Garo, E. (2025). Coumarins and betulinic acid analogues from Mammea americana and their inhibitory activities on oncogenic MAPK/ERK and PI3K/AKT pathways in human melanoma cells. Phytochemistry. https://doi.org/10.1016/j.phytochem.2025.114580
Vancouver
Han R, Balsiger T, Dobrzyński M, Dürr L, Hell T, Smieško M, et al. Coumarins and betulinic acid analogues from Mammea americana and their inhibitory activities on oncogenic MAPK/ERK and PI3K/AKT pathways in human melanoma cells. Phytochemistry. 2025. doi:10.1016/j.phytochem.2025.114580
BibTeX
@article{Han2025,
author = {Han, Ruzhe and Balsiger, Tamara and Dobrzyński, Maciej and Dürr, Lara and Hell, Tanja and Smieško, Martin and Solis, Pablo N and Hamburger, Matthias and Pertz, Olivier and Teufel, Robin and Garo, Eliane},
title = {Coumarins and betulinic acid analogues from Mammea americana and their inhibitory activities on oncogenic MAPK/ERK and PI3K/AKT pathways in human melanoma cells},
journal = {Phytochemistry},
year = {2025},
doi = {10.1016/j.phytochem.2025.114580}
}
EUVIMED